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The effect of mitral valve replacement on left ventricular
volume, mass, function and clinical symptoms was ex-
amined in 20 patients with chronic mitral regurgitation.
Pre- and postoperative echocardiograms demonstrated
that two outcomes could be defined. Left ventricular
dimension at end-diastole was reduced to normal post-
operatively in the 16 Group I patients, but was un-
changed in the 4 Group Ii patients. The Group I re-
sponse was associated with a dramatic reduction in left
ventricular mass and adecrease in clinical symptoms:
all 16 patients reached New York Heart Association
functional class I. No change in left ventricular mass was
seen in the Group II patients and all four remained
symptomatic despite continued medical therapy. Ex-
Chronic mitral regurgitation may be well tolerated for decades
despite progressive left ventricular and left atrial enlarge-
ment. Eventually. however , myocardial failure becomes
man ifest with the onset of fat igue and congestive symptoms .
Currently . the timing of mitral valve replacement in patients
with chronic mitral regurgitation is based almo st entirely on
clinical symptoms a~d the angiographic demonstration of a
substantial regurgitant volume 0-5). Mitral valve replace-
ment generally result s in Ii decrease in the symptoms of
pulmonary venous congest ion . Howe ver. in some patients
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amination of the preoperative echocardiographic mea-
surements indicates that these data have significant prog-
nostic value in predicting surgical outcome. When
ventricular dimension at end-systole exceeds 2.6 cm/nr'
or fractional shortening is less than 31% or end-systolic
wall stress index exceeds 195 mm Hg, all Group II pa-
tients are identified and there are no false positive results
in Group I.
It is concluded that echocardiographic measurements
of left ventricular size, function and wall stress can pro-
vide important prognostic information in patients with
chronic mitral regurgltation. Such data may allow im-
proved patient selection and a better definition of an
optimal time for mitral valve replacement.
with underlying covert myocardial dysfunction. correction
of mitral regurgitation may result in persistent left ventric-
ular dilation , an increase in systolic wall stress (afterload)
and adecrease in the systolic ejection fraction. Because it
is difficult to predict postop erati ve results and because of
the known complications of prosthetic valves, the opt imal
time for valve replacement has not been defined . Schuler
et al. (6) and Borow et al. (7) presented evidence that pre-
operative hemodynamic. echocardiographic and clinical data
can be useful in identifying high risk patients with chronic
mitral regurgitation. We have come to similar conclusion s
in patients with chronic aortic regurgitation (8.9), and the
present study represents our initial attempts to utilize the
echocardiogram in the assessment of patients with chronic
mitral regurgitation. From pre- and postoperative cch ocar-
diograms, we attempted to define the effect of mitral valve
replacement on left ventricular volume. mass and function
and to corre late these finding s with changes in clinical symp-
tom s. We also exam ined the preoperati ve data in an attempt
to search for variables that might predi ct the left ventricular
respon se to mitral valve replacement.
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Methods
Study groups. Twenty patients who underwent mitral
valve replacement for chronic mitral regurgitation between
1975 and 1981 were invited to participate in this study. Our
protocol was approved by the Committee on Research In-
volving Human Beings; informed consent was obtained in
all cases. Admission to the study requiredhighqualityecho-
cardiographic left ventricular studies, and the presence of
pure chronic mitral regurgitation (no evidence of mitral ste-
nosis); patients were excluded from the study if aortic valve
disease was present. The decision to perform mitral valve
replacement was made by clinicians not involved in this
study and was based on clinical and hemodynamic criteria.
All patientswere in New York Heart Associationfunctional
class II or III and all were being treated with digitalis and
diuretic drugs. The physical findings were typical of sig-
nificant mitral regurgitation; the chest X-ray films showed
cardiomegaly, and the electrocardiograms revealedleft ven-
tricular hypertrophy in 17 patients. Left ventricularcinean-
giography showed substantial mitral regurgitation in all pa-
tients; no regional wall motion abnormalities wereapparent.
Surgery. Mitral valve replacement was performed dur-
ing cold potassium cardioplegia. Fifteen porcine and five
Bjork-Shiley prosthetic valves were used. Three patients
(Cases 10, 19 and 20) had associated coronary bypass graft
surgery; none of these patients had angina. No patient had
evidence (by history or electrocardiogram) of a previous or
perioperative myocardial infarction and nonedevelopedevi-
dence of a postoperative paravalvular leak. Three patients
(Cases I, 15 and 19) had tricuspid valve repair and one
patient (Case 6) had an atrial septal defect corrected.
Cardiac catheterization measurements. All 20 pa-
tients underwent preoperative right and left heart catheter-
ization using routine clinical methods. The cardiac index
was determined using the Fick principle for oxygen. Left
ventricular end-diastolic volume (EDVa) and end-systolic
volume (ESVa) were determined using single plane angi-
ography (right anterior oblique protection, area-length method)
(10), and the systolic ejection fraction (SEF) was calculated
as:
SEF = (EDVa - ESVa) / EDVa· (I)
Echocardiographic measurements. Echocardiograms
were obtained with a Smith-Kline or a Hewlett-Packard
phased array ultrasonoscope and a 2.25 or 2.5 MHz trans-
ducer. An electrocardiogram (lead II) and blood pressure
were recorded at the time of each echocardiographic study.
Left ventricular dimension at end-diastole (Ded) was mea-
sured at the onset of the QRS complex. The dimension at
end-systole (Des) was measured as the smallest vertical
dimension between the left septal echo and the posterior
wall endocardium. Posterior wall thickness (Th) was mea-
sured from the leading edge of the epicardial echo to the
leading edge of the endocardial echo, with the gain adjust-
ment set to minimize the width of these signals. Likewise,
the septal thickness was measured from the leading edge of
the right septal echoes to the leading edge of the left septal
echoes. Fractional shortening (FS, expressed as the percent
change in left ventricular dimension from end-diastole to
end-systole) was calculated as:
FS = {(Ded - Des)/Ded} . 100. (2)
Fractional shortening was not determined when the septal
motion was paradoxical. Both dimensionat end-systole and
fractional shortening were usedas indexesof left ventricular
performance.
Ventricular volume measurements. Echocardiographic
estimatesof left ventricularvolume are known to be limited
by several major assumptions (II) . For this reason, we did
not select a single methodor regression equation to monitor
changes in chamber volume after surgery. Left ventricular
dimension at end-diastole was used as an index of end-
diastolic volume. Echocardiographic estimation of left ven-
tricular muscle mass is also dependent on various assump-
tions regarding ventricular dimensions . We, therefore, elected
to use an index of myocardial mass that does not require
major geometric assumptions. This index, termed the cross-
sectional area (CSA) of the left ventricular wall in a trans-
verse plane, was calculated from the echocardiographic di-
mension and wall thickness at end-diastole as:
CSA = {(Ded/2) + ThF - (Ded/2f. (3)
This index was developed by Sasayama et al. (12) and was
used in studieson the responseof the left ventricleto chronic
pressure overload. In studies of patients with chronic mitral
regurgitation (6) or chronic aortic regurgitation (8), muscle
cross-sectional area has been found to be unchanged in the
early postoperative perioddespite substantialchanges in left
ventricular volume.
Wall stress index. Quinones et al. (13) have shown that
noninvasive indexes of wall stress canbe estimatedas P(Rffh),
where P is the systolic (cuff) blood pressure, R is the left
ventricular radius (one-half the left ventricular dimension)
and Th is the average of the septal and posterior wall thick-
ness. By calculatingthe RlThratio at end-diastole(ed), end-
systole (es) and the average of end-diastole and end-systole
(mean), indexes of left ventricular systolic wall stress can
be determined; if P = peak systolic pressure, peak systolic
wallstress index = P(RlTh)cd , end-systolicwallstress index
= P(RITh)cs and a mean wall stress index = P(RlTh)mcan
can be estimated.
Postoperative dimension at end-diastole . All 20 patients
had pre- and postoperative (1. 7 ± I years after operation)
echocardiograms, blood pressure recordings and electro-
cardiograms. Assessment of clinical status using the New
York Heart Association functional classification and the pa-
tient's medication list was determined before and after op-
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eration by reviewing hospital charts, catheterization reports
and outpatient records and by telephone contact with each
patient.
The 20 patients were separated into two groups based on
the postoperative left ventricular dimension at end-diastole.
Group I patients (n = 16) had postoperative normalization
of left ventricular size (end-diastolicdimension decreased to
within 2 standard deviations of the average value for normal
subjects). Group II patients (n = 4) had persistent post-
operative left ventricular enlargement (end-diastolic dimen-
sion remained more than 2 standard deviations above the
average normal value). Our previous experience in studies
of patients with aortic insufficiency (8,9), coupled with the
publisheddata of others (6) and especially with the important
observations of Hirshfeld et al. (14), indicate not only that
this method of grouping patients is convenient and simple.
but also that prognosis after valve replacement is better in
patients with a postoperative decrease in heart size. The
normal rangeof left ventricular dimensions, fractional short-
ening and cross-sectional area has been defined and pub-
lished elsewhere (8).
Statistical analysis. All echocardiographic values are
normalized for body surface area. Data were analyzed for
statistical significance using both paired and unpaired Stu-
dent's t tests as appropriate. Changes were considered sig-
nificant at probability [pI values of less than 0.05. In the
assessment of the preoperative utility of the echocardio-
graphic data, we calculated sensitivity, specificity and pre-
dictive values of positive ( +) and negative ( - ) tests. The
following definitions were used.
Sensitivity = True positives/True positives
+ False negatives
Specificity = True negatives/False positive
+ True negatives
Predictive value ( +) = True positives/True positives
+ False positives
Predictive value (-) = True negatives/False negatives
+ True negatives
Results
The clinical, hemodynamic and echocardiographic data
from all 20 patients are shown in Tables I, 2 and 3. In
general, these patients had left ventricular and left atrial
enlargement and increased myocardial cross-sectional area.
Systolic function ranged from normal to moderately de-
pressed and all patients were symptomatic (functional class
II or Ill). On the basis of postoperative end-diastolic di-
mension, the patients were separated into two subgroups.
Group I patients had normal left ventricular end-diastolic
dimension and those in Group II had persistent left ven-
tricular enlargement at the time of the postoperative study
(Fig. I).
Group I (n = 16). Normalization of left ventricular
end-diastolicdimension « 3.3 cm/rn") was associated with
a decrease in muscle cross-sectional area in all 16 patients.
Although the average muscle cross-sectional area remained
slightly above normal. 9 of the 16 patients had normal
postoperative values for this index of left ventricular mass
(normal cross-sectional area < 10 cmvrrr'). There was no
significant change in left atrial dimension. Despite the pres-
ence of abnormal postoperative septal motion in 10 patients
and a decrease in fractional shortening in 15 patients. all
patients improved symptomatically and attained functional
class I.
Group II (n = 4). All four patients in this group with
persistent left ventricular enlargement had markedly in-
creased muscle cross-sectional area at the time of the post-
operative study. Systolic function was grossly abnormal in
these patients and all four remained symptomatic in func-
tional class II or higher. It is thus clear that these two groups
of patients had distinctly different outcomes after the sur-
gical correctionof chronic mitral regurgitation. In an attempt
to identify variables that might predict a suboptimal result,
as occurred in patients in Group II, we then examined the
preoperative echocardiographic data.
Predictive indexes. Left ventricular end-diastolic di-
mension tended to be larger in Group I than in Group II
(Fig. 2). but this trend did not achieve statistical signifi-
cance. Likewise. the average values for cross-sectional area
were not significantly different between the two groups. In
contrast. the differences in the average values for left ven-
tricular end-systolic dimension did achieve statistical sig-
nificance (p < 0.0 I); end-systolic dimension was greater
than 2.6 cm/rn ' in all 4 patients in Group II, but in only 2
of the 16 patients in Group I. Fractional shortening was also
significantly different in the two groups (p < 0.01); it was
less than 31 % in all Group II patients, but in only 2 of the
16 patients in Group I. Thus. values for end-systolic di-
mension greater than 2.6 cm/m ' or fractional shortening
less than 31 % are predictive of a Group II outcome: the
sensitivity. specificity and predictive value of a positive test
(either end-systolic dimension greater than 2.6 cm/rrr' or
fractional shortening less than 31 %) are 100. 88 and 66%,
respectively.
When leftventriculardimensions at end-diastole and end-
systole (not normalized for body surface area) were ex-
amined. similar trends were apparent. No difference in the
average values for end-diastolic dimension was found be-
tween Groups I and II. However, the average value for end-
systolic dimension was statistically different between the
two groups (p < 0.0 I). End-systolic dimension was 4.6 em
or greater in all patients in Group II (100% sensitivity). but
only four patients in Group I had values in this range. The
resultant specificity (75 c/c.) and predictive value (50%) are
therefore lower when non-normalized values are used than
when values normalized for body surface area are used.
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Table 1. Data From 20 Patients With Chronic Mitral Regurgitation
Cause of
Age(yr). Sex PA Mitral
Case & BSA Rhythm BP SiD (mean) LVEDP SEF-Angio CI Regurgitation
Group I
I 45F 1.6 AF 130/85 37/20 (28) 15 68% 2.4 MVP
2 65F 1.5 AF 130170 48/20 (33) 10 66% 2.4 RHD
3 50M 1.9 NSR 130/80 48/ 8 (23) 8 56% 2.9 MVP
4 52M 1.9 NSR 135/80 65/25 (45) 25 75% 2.0 MVP/SBE
5 45F 1.2 AF 120170 53/24 (31) 20 71% 2.4 MVP
6 63M 1.7 AF 130/80 29/ 10 (19) 8 75% 2.4 MVP
7 52M 2.0 NSR 135/84 54/26 (32) 25 57% 2.7 MVP/ruptured chordae
8 67M 1.9 AF 135/90 50/10 (28) 13 59% 2.8 SBElflail PMVL
9 60M 1.7 NSR 120170 3511 5 (20) 7 MVP
10 75M 1.9 Paced 110/80 80143 (57) 17 59% 2.7 MVP
11 54M 1.9 AF 130/80 35/20 (26) 22 48% 2.5 Ruptured chordae
12 47M 1.9 NSR 135/80 19/ 9 (11) 20 69% 1.9 MVP
13 12F 1.8 NSR 135170 25/ 10 (15) 10 70% 2.3 MVP
14 67M 2.0 AF 11 5170 52/21 (31) 12 66% 1.3 SBE/flail PMVL
15 73F 1.7 AF 120170 70/30 (47) 12 68% 1.7 MVP/SBE
16 47M 2.1 NSR 135/69 4011 6 (24) 15 59% 3.1 MVP
Mean 46119 (29) 15 64% 2.4
± SE 4/ 2 ( 3) I 2% 0.1
Group II
17 58F 1.8 NSR 140/100 80/40 (54) 7 41% 1.9 Vasculitis
18 63M 1.6 NSR 110170 55/18 (36) 8 74% 2.3 SBE
19 64F 1.7 AF 11 0170 60/32 (40) 20 46% 2.2 RHD
20 12M 1.9 NSR 120/80 30118 (23) 15 33% 2.1 MVP
Mean 56/29 (38) 12 48% 2.1
± SE 10/ 5 ( 6) 3 9% 0. 1
P value* NS NS NS NS NS NS
*Group I versus Group II. AF = atrial fibrillation; BP = cuff blood pressure (mm Hg): BSA = body surface area (rrr'): CI = cardiac index
(liters/min per rrr ' ): D = diastolic; F = female; LVEDP = left ventricular end-diastolic pressure (rnrn Hg): M = male; MVP = mitral valve prolapse;
NS = not significant (p > 0.05); NSR = normal sinus rhythm; p = probability; PA = pulmonary artery pressure (mm Hg); PMVL = posterior mitral
valve leaflet; RHD = rheumatic heart disease; S = systolic; SBE = subacute bacterial endocarditis; SE = standard error; SEF-Angio = angiographic
systolic ejection fraction.
Individual values for the three indexes of left ventricular
systolic wall stress are shown graphically in Figure 3 . There
was no significant difference in the average values for the
product of systolic arterial pressure and radius/thickness
ratio at end-diastole (P[RlTh]cd) or mean wall stress (P
[RlThl mean) between the two groups. However . there was a
significant difference in the index of end-systolic stress
(P[RlTh]es) between the two groups (p < 0.0 I) ; all four
patients in Group II had an end-systolic wall stress index
of 195 mm Hg or greater compared with 6 of the 16 patients
in Group I. Thus, a value for end-systolic wall stress of 195
or greater predi cts a Group II outcome with a sensitivity of
100%, a speci ficity of 63% and a pred ict ive value of 40%.
We have thus identified three echocardiographic vari-
ables that appear to have clinical value in the preoperative
assessment of patients with chronic mitral regurgitation .
The limits that we used were selected so as to include all
Group II patient s ( 100% sensitivity). In an attempt to im-
prove the spec ificity and predictive values of a positi ve or
negative test , we also asse ssed combinations of these echo-
cardiographic variables. As shown in Figure 4, the com-
bination of an end-systolic dimension greater than 2.6 mm/rrr'
and fraction shortening less than 31% identifies all Group
I patient s with no false positive results ( 100% sensitivity
and 100% speci ficity) . The combination of an end-sys tolic
dimension greater than 2.6 crn/m? and end- systolic wall
stress of 195 mm Hg or greater likewi se identifies all Group
II patients, but there is one false positive result (specificity
94%).
Discussion
In properl y selected patients, the surgical correction of
chronic mitral regur gitation results in hemodynamic and
symptomatic impro vement. Unfortun ately, however, not all
patient s improve after mitral valve replacement. The iden-
tification of such patient s before surgery would seem to be
of pivotal importance , not only because they might present
an increased surgical risk , but also because they might ben-
efit from agress ive perioperative medical therapy (15 ). Al-
though a number of published report s (16) include physi-
ologic, clinical and surgical data from patients undergoing
mitral valve replacement , relatively few (6.7, 17- 21) assess
the potenti al value of preoperat ive data as a predictive tool.
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Table 2. Preoperative and Postoperative Echocardiographic Data
Oed Des Septal LA CSA
(cm/ rrr' ) (cm/rrr' j FS Motion (cm /rrr') (cmv rrr') FC
Case Pre Post Pre Post Pre Post Post Pre Post Pre Post Pre Post
Group I
I 3.9 2.6 2.5 1.9 37% 26% Hypo 3.4 3.8 12.8 9.0 2 I
2 4.0 2.7 2.3 1.7 42% 39% Akin 3.5 3.0 14.7 10.7 2 It
3 3.9 2.4 2.5 1.9 37Cf< N/A Para 2.2 2.1 12.5 9.1 2 I
4 3.9 2.9 2.6 1.8 33% 380/< Nml 2.9 2.9 14.1 10.9 2 1
5 4.3 3.5 2.9 2.5 33% 30% Nml 4.1 3.0 18.2 13.9 3 I
6 4.1 2.6 2.7 1.9 34% 29% Nml 2.6 2.6 14.8 9.0 3 1
7 3.5 2.7 2. 1 1.7 41% 360/< Nml 2.6 2.6 12.6 6.6 2 1:1:
8 3.8 2.9 2. 1 1.8 44% N/A Para 3.2 3.1 13.6 13.5 2 I
9 4.0 2.9 2.6 2.5 35% N/A Para 2.6 2.2 12.8 9.8 3 1
10 3.2 2.6 2. 1 2.1 33% 200/< Akin 2.1 2.1 9.0 7.7 3 I
II 3.4 2.9 2.5 2.4 28% 16% Akin 2.6 2.7 11.0 10.7 2 1:1:
12 3.4 2.9 2. 1 2. 1 38ch 2N Nml 2.6 2.5 13.8 10.7 2 I
13 3.2 2.9 2.3 2.3 28% 21ch Akin 2.7 2.8 11.9 9.7 2 1:1:
14 3. 1 2.7 2. 1 2.2 32% 200/< Nml 2.5 2.6 11.3 8.9 3 I
15 3.4 2.9 2.4 2.4 31% 180/< Akin 3.2 2.8 17.1 13.5 3 1:1:
16 3.3 2.8 2. 1 2.2 42% 20'7< Aki n 2.8 2.5 11.0 8.3 3 I
Mean 3.7 2.8 2.4 2. 1 35o/r 26% 2.9 2.7 13.2 10.3
± SE 0. 1 0.05 0.08 0.08 ICh 2°k 0. 1 0.1 0.6 0.5
P value* < 0.001 < 0.0 1 < 0.01 NS < 0.001
Group II
17 3.8 4.0 2.7 3.4 29% 14% Hypo 2.8 2.9 13.6 14.3 3 2:1:
18 4. 1 3.9 2.9 3.0 30'1i 23% Nml 3.4 3.4 14.9 14.1 3 2:1:
19 4.1 3.8 2.9 3.4 29°k N/A Para 2.9 2.9 18.2 13.9 3 2:1:
20 4.2 4. 2 3.4 3.7 19% 13% Hypo 3. 1 3. 1 14.9 14.9 4 4~
Mean 4. 1 4.0 3.0 3.4 27'1i 17ch 3.1 3.1 15.4 14.3
:!: SE 0. 1 0.1 0.2 0.2 3%· N 0.2 0.2 1.0 0.2
p value* NS NS NS NS NS
P valuet NS < 0.001 < 0.01 < 0.001 < 0.01 NS NS NS NS < 0.01
"Preoperative versus postoperative. tGroup I versus Group II. :j: Diurctic drugs. ~U n llladi ng agent. Akin = akinetic; CSA = muscle cross-sectional
area:Ded = dimensionat end-diastole; Des = dimensionatend-systole; FC = New York Heart Association functional class; FS = fract ional shortening;
Hypo = hypokinetic: LA = left atrial size: N/A = not calculated because of paradoxical septal motion; Nml = normal; Para = paradoxical; Post =
postoperative: Pre = preoperative.
ments for medication. In contrast, we found no significant
change in chamber size or myocardial mass in four patients
(Group 11) who remained symptomatic despite continued
medical treatment (Table 3).
Predictive indexes. Having thus defined two subsets of
patients. we then examined the preoperative data in an at-
tempt to identify variables that might be predictive of the
Group II result. It is well recognized that a suboptimal
surgical result can be expected in patients with marked left
Table 3. Medications at Late Follow-up
For this reason, we designed this study to define the effects
of mitral valve replacement on left ventricular volume. mass
and function in patients with chronic mitral regurgitation
and to evaluate preoperative echocardiographic data for clues
that might be predictive of a suboptimal result. We (8 ,9)
and others (22- 25) have previously used these methods in
patients with chronic aortic regurgitation.
Postoperati ve changes. Most patients in this study had
an impressive decrease in left ventricular chamber size and
myocardial mass after mitral valve replacement. The change
in end-diastolic dimension Cra ble 2) represents an approx-
imate 55% decrease in left ventricular volume. Although
the average value for muscle cross-sectional area in this
group did not reach normal, there was a highly significant
decrease in this index of left ventricular mass. Such a change
in cross-sectional area represents an approximate 52% de-
crease in mass. This postoperative decrease in chamber size
and regression of hypertrophy was associated with a distinct
improvement in symptoms and a decrease in the require-
No cardiac drugs
Digitalis only
Digitalis and diuretic drug
Digitalis , diuretic drug
and unloading agent
Group [
In = 16)
1 (6%)
10 (63%)
5 (31'1i )
o
Group II
In = 4)
a
a
3 (75%)
1 (25%)
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Figure l. Pre- and postoperative echocar- Ded (cm/m2 ) Des (cm/m 2 ) FS(%) CSA (cm/m 2 )
diographic data from 20 patients with chronic
mitral regurgitation. The average values for
Group [ (n = 16) are indicated by the closed 4.5 3.5~ 35.. 17.5circles; Group II (n = 4) data arc shown as 2- ~ ~open squares. After mitral valve replace-
ment, there was a significant decrease in the 3.5
-.
2.5 25.. 12.5
-,left ventricular dimension at end-diastole ~*(Ded), end-systole (Des) and muscle cross-
sectional area (CSA) in Group I. In Group
II, the changes in these variables did not 2.5 1.5 15.. 7.5
achieve statistical significance. Fractional r f f fshortening (FS) declined in both groups, but
these changes achieved statistical signifi- Preop postop Preop Postop Preop Postop Preop Postop
cance only in Group 1. *p < 0.01. Postop
= postoperative; Preop = preoperative.
ventricular enlargement, poor systolic function and in-
creased systolic wall stress; our data are consonant with this
general impression. An end-diastolic dimension greater than
4.0 crn/nr', an end-systolicdimension greater than 2.6 cm/nr' ,
a fractional shortening less than 3[% or a systolic wall stress
index greater than 195 mm Hg is predictive of a poor surgical
result. Although the individual measurements have limited
predictive accuracy, combinations of these variables have
considerable value.
Most published reports that address the issue of changes
in left ventricular function after the surgical correction of
chronic mitral regurgitation do not examine specific subgroups
of patients, as we did in the present study. Schuler et al.
(6), however, did report pre- and postoperative echocardio-
graphic data in two groups of patients with chronic mitral
regurgitation; 12 patients (their Group I) had a marked de-
crease in left ventricular volume and mass and 4 patients
(their Group II) had no significant change in these variables.
In the study of Schuler et al., an end-diastolic dimension
greater than 7.0 em, an end-systolic dimension greater than
5.0 em and a low normal or decreased systolic ejection
fraction « 63%) were suggested as variables that were
predictive of a suboptimal response to mitral valve replace-
ment. However, their Group I patients had a smaller body
surface area than those in Group II. When corrected for
body surface area, there was no significant difference in the
average values for end-diastolic dimension between Group
I and Group II (3.7 ± 0.1 versus 4.4 ± 0.3 cm/rrr', dif-
ference not signifi cant). In contrast, there was a significant
difference between the mean values for normalized end-
systolic dimension. Moreover, the data of Schuler et al. (6)
indicate that an end-systolic dimension greater than 2.6 cm/nr'
has a sensitivity of 100% (that is, it identifies all Group II
patients) with only one false positive fi nding. These results
are nearly identical to those in our study. Although both
studies are limited by small numbers of patients, the data
are in remarkably close agreement.
Borow et al. (7) reported preoperative angiographicdata
from 16 patients with mitral regurgitation and found that
patients with an end-systolic volume less than 60 ml/rrr' had
distinctly better postoperative ventricular function than those
with an end-systolic volume greater than 60 ml/rn". A value
Oed (cm/m2) Des (cm/m 2) FS ('lfl)
5.5 4 .5
•
40
.,
Ie
Figure 2. Preoperative data from the in- 4.5 3.5 +!0dividual patients in Groups (GRP) I (closed • olfJ 2NS•
DO 2* --~--------c---circles) and II (open squares). There was e\'t • 30
.. DO i*no significant difference (NS) in preoper- 0 --~-------p-----ative dimension at end-diastole (Ded) be- 3 .5 t 2.5tween the two groups. The dimension at .. !
•
-end-systole (Des) was significantly larger 20 0
and fractional shortening (FS) was signif-
icantly lower in Group II (* P < 0.01). The 2.5 1.5
dashed lines (Des 2.6 cm/rrr'and FS 31%) r f f
represent limits that have prognostic value
(see text). GAP I GAP II GAP I GAP II GAP I GAP II
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p. (RITh)ed P • (R/Th)mean p.(RITh)es
550 I 450 350 0
0
. :I-•I 00 0450 -r tNS
350 t 2~~ NS• --ik-------~---• : ! • !00 0 &350 • 250 :I 150
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Figure 3. Preoperative indexes of left ven-
tricular wall stress. The product of systolic
arterial pressure and the radius/thickness ra-
tio (P'[R/Th]) at end-systole (es) was signif-
icantly larger in Group II than in Group I
(right panel). The elevated value of this in-
dex of late systolic wall stress in the Group
II patients reflects a form of afterload excess
which is associated with a large end-systolic
dimension and decreased fractional short-
ening. The dashed line represents a limit
(195 mm Hg) which has prognostic value.
ed = end-diastole; NS = not significant.
of 60 ml/rrr' roughly corresponds to an echocardiographic
end-systolic dimension of 5 em (or approximately 2.6 cm/rrr)
and, in this regard, our data are in close agreement with
those of Borow et al. (7). In contrast, Boucher et al. (19)
and Phillips et al. (20) concluded that the radionuclide eval-
uation of left ventricular function had little value in pre-
dicting the postoperative volume, mass or ejection fraction
or the presence or absence of symptoms. Carabello et al.
(21) found that the ratio of end-systolic wall stress/end-
systolic volume was marginally better than end-systolic vol-
ume alone in predicting the postoperative result. However,
with few exceptions, an end-systolic volume of 60 ml/rn?
provided excellent separation between the satisfactory and
unsatisfactory postoperative result in their patients.
Systolic wall stress. Systolic wall stress remains normal
in chronic pressure or volume overload until the increase in
chamber radius is no longer accompanied by an appropriate
increase in chamber wall thickness; at this point ventricular
decompensation occurs (26). It is on this basis that preop-
erative indexes of wall stress were assessed for prognostic
value. In the present study, we examined three indexes of
systolic wall stress and found that one, the product of arterial
systolic pressure and the end-systolic radius/thickness ratio
(an index of late systolic wall stress), had considerable pre-
dictive accuracy, especially when combined with end-sys-
tolic dimension. This simplified index of late systolic wall
stress derived from echocardiographic and cuff pressure
measurements has been validated by Quinones et al. (13)
and others (27). This index has special clinical utility be-
cause its calculation does not depend on a complex geo-
metric formula, but is determined using routine M-mode
echocardiographic measurements. These simplifiedmethods
are not as theoretically appealing as an analysis of multiple
stress-shortening coordinates, but they are very appealing
in a practical sense.
Implications. On the basis of these data, we conclude
that echocardiographic measurementsof left ventricularsize,
function and wall stress can provide important prognostic
4.0
Figure 4. Preoperative data from the two groups
are examined in combination. Group I data are
indicated byclosed circles; Group IIdata areshown
by the open squares. Variables that have prog-
nostic value arethe dimension atend-systole (Des),
fractional shortening (FS) and the index of late
systolic stress (P[ R/Thles). This index consists of
the product of systolic arterial pressure (P) and
the end-systolic radius/thickness ratio (R/Th)es.
If the end-systolic dimension is greater than 2.6
cm/rrr' and the fractional shortening is less than
31 %. all Group 11 patients are identified with no
false positive findings (left panel). If the end-
systolic dimension is greater than 2.6 cm/rrr'and
P(R/Th)es is greater than 195 mm Hg, all Group
II patients are identified, but there is one false
positive result (right panel).
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information in patients with chronic mitral regurgitation.
Such prognostic information should allow improved patient
selection and, perhaps, an even better definition of an op-
timal time for mitral valve replacement.
We are indebted to Susan Pierce for her assistance in preparing this manu-
script and to Linda Woodbury for her assistance in performing the echo-
cardiographic examinations.
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